Aeglea BioTherapeutics GAAP EPS of -$1.00 beats by $0.02, revenue of $18.73M beats by $1.33M
- Aeglea BioTherapeutics press release (NASDAQ:AGLE): FY GAAP EPS of -$1.00 beats by $0.02.
- Revenue of $18.73M beats by $1.33M.
- As of December 31, 2021, the company had available cash, cash equivalents, marketable securities and restricted cash of $95.0 million